Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Diagnostic radiopharmaceuticals. Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis
This report elaborates on the current development of the Diagnostic Nuclear Medicines industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Bayer
Nordion
Navidea
China Isotope & Radiation
SIEMENS
Eli Lilly
Jubilant Pharma
Lantheus
Novartis
Dongcheng
Curium Pharmaceuticals
Triad Isotopes
Bracco Imaging
GE Healthcare
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Tc-99m
F-18
Other
Application:
Oncology
Cardiology
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Diagnostic Nuclear Medicines Industry Overview
-
1.1.1 Diagnostic Nuclear Medicines Market Scope and Market Segments
-
1.1.2 Diagnostic Nuclear Medicines Industry Characteristics
-
1.1.3 Global and China Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Diagnostic Nuclear Medicines Production Value and Growth Rate (2017-2028)
-
1.2 Global Diagnostic Nuclear Medicines Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Tc-99m
-
1.2.2 F-18
-
1.2.3 Other
-
1.3 Global Diagnostic Nuclear Medicines Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Oncology
-
1.3.2 Cardiology
-
1.3.3 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Diagnostic Nuclear Medicines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Diagnostic Nuclear Medicines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Diagnostic Nuclear Medicines Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Diagnostic Nuclear Medicines Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Diagnostic Nuclear Medicines Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Diagnostic Nuclear Medicines Industry Porter's Five Forces Model Analysis
-
2.2.3 Diagnostic Nuclear Medicines Industry PEST Analysis
-
2.3 Diagnostic Nuclear Medicines Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Diagnostic Nuclear Medicines Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Diagnostic Nuclear Medicines Industry
Chapter 3 Global and China Diagnostic Nuclear Medicines Market, by Manufacturer
-
3.1 Global and China Diagnostic Nuclear Medicines Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Diagnostic Nuclear Medicines Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Diagnostic Nuclear Medicines Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Diagnostic Nuclear Medicines Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Diagnostic Nuclear Medicines Market Top 3 Players
Chapter 4 Global and China Diagnostic Nuclear Medicines Market, by Type (2017-2028)
-
4.1 Diagnostic Nuclear Medicines Market Trend, by Type
-
4.2 Global Diagnostic Nuclear Medicines Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Diagnostic Nuclear Medicines Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Diagnostic Nuclear Medicines Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Diagnostic Nuclear Medicines Price Trend, by Type (2017-2028)
-
4.3 China Diagnostic Nuclear Medicines Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Diagnostic Nuclear Medicines Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Diagnostic Nuclear Medicines Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Diagnostic Nuclear Medicines Price Trend, by Type (2017-2028)
Chapter 5 Global and China Diagnostic Nuclear Medicines Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Diagnostic Nuclear Medicines Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Diagnostic Nuclear Medicines Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Diagnostic Nuclear Medicines Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Diagnostic Nuclear Medicines Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Diagnostic Nuclear Medicines Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Diagnostic Nuclear Medicines Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Diagnostic Nuclear Medicines Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Diagnostic Nuclear Medicines Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Diagnostic Nuclear Medicines Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Diagnostic Nuclear Medicines Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Diagnostic Nuclear Medicines Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Diagnostic Nuclear Medicines Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Diagnostic Nuclear Medicines Market Analysis
-
7.1 North America Diagnostic Nuclear Medicines Market, by Type
-
7.2 North America Diagnostic Nuclear Medicines Market, by Application
-
7.3 North America Diagnostic Nuclear Medicines Market Analysis and Forecast, by Country
-
7.3.1 United States Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Diagnostic Nuclear Medicines Market Analysis
-
8.1 Europe Diagnostic Nuclear Medicines Market, by Type
-
8.2 Europe Diagnostic Nuclear Medicines Market, by Application
-
8.3 Europe Diagnostic Nuclear Medicines Market Analysis and Forecast, by Country
-
8.3.1 Germany Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Diagnostic Nuclear Medicines Market Analysis
-
9.1 APAC Diagnostic Nuclear Medicines Market, by Type
-
9.2 APAC Diagnostic Nuclear Medicines Market, by Application
-
9.3 APAC Diagnostic Nuclear Medicines Market Analysis and Forecast, by Country
-
9.3.1 China Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Diagnostic Nuclear Medicines Market Analysis
-
10.1 Latin America, Middle East and Africa Diagnostic Nuclear Medicines Market, by Type
-
10.2 Latin America, Middle East and Africa Diagnostic Nuclear Medicines Market, by Application
-
10.3 Latin America, Middle East and Africa Diagnostic Nuclear Medicines Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Diagnostic Nuclear Medicines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Diagnostic Nuclear Medicines Company Profiles
-
11.1 Bayer
-
11.1.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Bayer Diagnostic Nuclear Medicines Product Profiles, Application and Specification
-
11.1.3 Bayer Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Nordion
-
11.2.1 Nordion Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Nordion Diagnostic Nuclear Medicines Product Profiles, Application and Specification
-
11.2.3 Nordion Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Navidea
-
11.3.1 Navidea Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Navidea Diagnostic Nuclear Medicines Product Profiles, Application and Specification
-
11.3.3 Navidea Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 China Isotope & Radiation
-
11.4.1 China Isotope & Radiation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 China Isotope & Radiation Diagnostic Nuclear Medicines Product Profiles, Application and Specification
-
11.4.3 China Isotope & Radiation Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 SIEMENS
-
11.5.1 SIEMENS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 SIEMENS Diagnostic Nuclear Medicines Product Profiles, Application and Specification
-
11.5.3 SIEMENS Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Eli Lilly
-
11.6.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Eli Lilly Diagnostic Nuclear Medicines Product Profiles, Application and Specification
-
11.6.3 Eli Lilly Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Jubilant Pharma
-
11.7.1 Jubilant Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Jubilant Pharma Diagnostic Nuclear Medicines Product Profiles, Application and Specification
-
11.7.3 Jubilant Pharma Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Lantheus
-
11.8.1 Lantheus Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Lantheus Diagnostic Nuclear Medicines Product Profiles, Application and Specification
-
11.8.3 Lantheus Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Novartis
-
11.9.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Novartis Diagnostic Nuclear Medicines Product Profiles, Application and Specification
-
11.9.3 Novartis Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Dongcheng
-
11.10.1 Dongcheng Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Dongcheng Diagnostic Nuclear Medicines Product Profiles, Application and Specification
-
11.10.3 Dongcheng Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Curium Pharmaceuticals
-
11.11.1 Curium Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Curium Pharmaceuticals Diagnostic Nuclear Medicines Product Profiles, Application and Specification
-
11.11.3 Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Triad Isotopes
-
11.12.1 Triad Isotopes Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Triad Isotopes Diagnostic Nuclear Medicines Product Profiles, Application and Specification
-
11.12.3 Triad Isotopes Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Bracco Imaging
-
11.13.1 Bracco Imaging Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Bracco Imaging Diagnostic Nuclear Medicines Product Profiles, Application and Specification
-
11.13.3 Bracco Imaging Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 GE Healthcare
-
11.14.1 GE Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 GE Healthcare Diagnostic Nuclear Medicines Product Profiles, Application and Specification
-
11.14.3 GE Healthcare Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Diagnostic Nuclear Medicines Industry Investment Prospect and Risk Assessment
-
12.1 Diagnostic Nuclear Medicines Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Diagnostic Nuclear Medicines Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure China Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Global Diagnostic Nuclear Medicines Production Value and Growth Rate (2017-2028)
-
Figure China Diagnostic Nuclear Medicines Production Value and Growth Rate (2017-2028)
-
Figure Global Diagnostic Nuclear Medicines Market Size and Growth Rate of Tc-99m (2017-2028)
-
Figure Global Diagnostic Nuclear Medicines Market Size and Growth Rate of F-18 (2017-2028)
-
Figure Global Diagnostic Nuclear Medicines Market Size and Growth Rate of Other (2017-2028)
-
Figure Global Diagnostic Nuclear Medicines Market Size and Growth Rate of Oncology (2017-2028)
-
Figure Global Diagnostic Nuclear Medicines Market Size and Growth Rate of Cardiology (2017-2028)
-
Figure Global Diagnostic Nuclear Medicines Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Diagnostic Nuclear Medicines Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Diagnostic Nuclear Medicines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Diagnostic Nuclear Medicines Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Diagnostic Nuclear Medicines Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Diagnostic Nuclear Medicines Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Diagnostic Nuclear Medicines Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Diagnostic Nuclear Medicines Market Share, by Manufacturer in 2021
-
Figure Global and China Diagnostic Nuclear Medicines Market Share, by Manufacturer in 2022
-
Table Global Diagnostic Nuclear Medicines Sales Volume, by Type (2017-2028)
-
Table Global Diagnostic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Figure Global Diagnostic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Table Global Diagnostic Nuclear Medicines Sales Value, by Type (2017-2028)
-
Table Global Diagnostic Nuclear Medicines Sales Value Share, by Type (2017-2028)
-
Figure Global Diagnostic Nuclear Medicines Price Trend, by Type (2017-2028)
-
Table China Diagnostic Nuclear Medicines Sales Volume, by Type (2017-2028)
-
Table China Diagnostic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Figure China Diagnostic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Table China Diagnostic Nuclear Medicines Sales Value, by Type (2017-2028)
-
Table China Diagnostic Nuclear Medicines Sales Value Share, by Type (2017-2028)
-
Figure China Diagnostic Nuclear Medicines Price Trend, by Type (2017-2028)
-
Table Global Diagnostic Nuclear Medicines Sales Volume, by Application (2017-2028)
-
Table Global Diagnostic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Figure Global Diagnostic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Table Global Diagnostic Nuclear Medicines Sales Value, by Application (2017-2028)
-
Table Global Diagnostic Nuclear Medicines Sales Value Share, by Application (2017-2028)
-
Figure Global Diagnostic Nuclear Medicines Sales Value Share, by Application (2017-2028)
-
Table China Diagnostic Nuclear Medicines Sales Volume, by Application (2017-2028)
-
Table China Diagnostic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Figure China Diagnostic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Table China Diagnostic Nuclear Medicines Sales Value, by Application (2017-2028)
-
Table China Diagnostic Nuclear Medicines Sales Value Share, by Application (2017-2028)
-
Figure China Diagnostic Nuclear Medicines Sales Value Share, by Application (2017-2028)
-
Figure China Diagnostic Nuclear Medicines Production, Import, Consumption and Export (2017-2022)
-
Figure North America Diagnostic Nuclear Medicines Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Diagnostic Nuclear Medicines Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Diagnostic Nuclear Medicines Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Diagnostic Nuclear Medicines Production, Import, Consumption and Export (2017-2022)
-
Table North America Diagnostic Nuclear Medicines Sales Volume, by Type (2017-2028)
-
Table North America Diagnostic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Figure North America Diagnostic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Table North America Diagnostic Nuclear Medicines Sales Volume, by Application (2017-2028)
-
Table North America Diagnostic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Figure North America Diagnostic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Figure United States Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure United States Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Canada Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Table Europe Diagnostic Nuclear Medicines Sales Volume, by Type (2017-2028)
-
Table Europe Diagnostic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Figure Europe Diagnostic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Table Europe Diagnostic Nuclear Medicines Sales Volume, by Application (2017-2028)
-
Table Europe Diagnostic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Figure Europe Diagnostic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Figure Germany Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure UK Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure UK Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure France Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure France Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Italy Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Spain Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Poland Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Russia Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Table APAC Diagnostic Nuclear Medicines Sales Volume, by Type (2017-2028)
-
Table APAC Diagnostic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Figure APAC Diagnostic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Table APAC Diagnostic Nuclear Medicines Sales Volume, by Application (2017-2028)
-
Table APAC Diagnostic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Figure APAC Diagnostic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Figure China Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure China Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Japan Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure India Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure India Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Diagnostic Nuclear Medicines Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Diagnostic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Diagnostic Nuclear Medicines Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Diagnostic Nuclear Medicines Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Diagnostic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Diagnostic Nuclear Medicines Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Diagnostic Nuclear Medicines Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Diagnostic Nuclear Medicines Sales Value and Growth Rate (2017-2028)
-
Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bayer Product Profiles, Application and Specification
-
Table Bayer Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Nordion Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Nordion Product Profiles, Application and Specification
-
Table Nordion Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Navidea Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Navidea Product Profiles, Application and Specification
-
Table Navidea Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table China Isotope & Radiation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table China Isotope & Radiation Product Profiles, Application and Specification
-
Table China Isotope & Radiation Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table SIEMENS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table SIEMENS Product Profiles, Application and Specification
-
Table SIEMENS Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Eli Lilly Product Profiles, Application and Specification
-
Table Eli Lilly Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Jubilant Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Jubilant Pharma Product Profiles, Application and Specification
-
Table Jubilant Pharma Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Lantheus Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Lantheus Product Profiles, Application and Specification
-
Table Lantheus Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Dongcheng Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Dongcheng Product Profiles, Application and Specification
-
Table Dongcheng Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Curium Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Curium Pharmaceuticals Product Profiles, Application and Specification
-
Table Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Triad Isotopes Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Triad Isotopes Product Profiles, Application and Specification
-
Table Triad Isotopes Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bracco Imaging Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bracco Imaging Product Profiles, Application and Specification
-
Table Bracco Imaging Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table GE Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GE Healthcare Product Profiles, Application and Specification
-
Table GE Healthcare Diagnostic Nuclear Medicines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
